LowreyGH. Growth and Development of Children(6th Edition). Chicago: Book Medical Publishers Inc., 1973; 1–16.
2.
TannerJM. Foetus Into Man: Physical Growth from Conception to Maturity. London: Open Books, 1978; 167–205.
3.
TannerJM. Growth at Adolescence(2nd Edition). Oxford: Blackwell, 1962; 28–39.
4.
MarshallWA. Interrelationships of skeletal maturation, sexual development and somatic growth in man. Ann Hum Biol1974; 1: 29–40.
5.
LejarragaHMelettiIBioccaSAloncoC. Secular trend and influence of social class, province of residence and city size on height & weight of 15,412 Argentinian adolescents (abstract). In: Fifth International Auxology Congress. London: Smith-Gordon, 1988; 55.
6.
TannerJMWhitehouseRHMarshallWACarterBS. Prediction of adult height from height, bone age, and occurrence of menarche at ages 4 to 16 with allowance for midparent height. Arch Dis Childh1975; 50: 14–26.
7.
PetersonKSuperCHerrevaM. Biological and social predictors of nutritional status at 6 months of age in Columbian infants at high risk of malnutrition (abstract). In: Fifth International Auxology Congress. London: Smith-Gordon, 1988; 41.
8.
RabinMSWestermeyerVW. Recovery of growth hormone in purification of corticotropin. Proc Soc Exp Biol Med1951; 78: 550–1.
9.
WilhelmiAEFishmanJBRussellJA. A new preparation of crystalline anterior pituitary growth hormone. J Biol Chem1948; 176: 735–45.
10.
RabinMS. Human growth hormone. Recent Prog Horm Res1959; 15: 71–114.
11.
KnobilEGreepRO. The physiology of growth hormone with particular reference to its action in the Rhesus monkey and the species specificity problem. Recent Prog Horm Res1959; 15: 1–69.
12.
ButtWR. Growth hormone. In: ButtWR. Hormone Chemistry(2nd Edition).New York: John Wiley & Sons Inc.1975; 96–115.
13.
BaumannG. Growth hormone binding proteins and various forms of growth hormone: Implications for measurements. Acta Paediatr Scand (Suppl) 1990; 370: 72–80.
14.
CelnikerACChenABWertRMShermanBM. Variability of circulating growth hormone using commercial immunoassays. J Clin Endocrinol Metab1989; 68: 469–76.
15.
FrankenneFClossetJGomezFThe physiology of growth hormones in pregnant women and partial characterisation of the placental GH variant. J Clin Endocrinol Metab1988; 66: 1171–9.
BaumannGMacCartJAmburnK. The molecular nature of circulating growth hormone in normal and acromegalic man: Evidence for a principal and minor monomeric forms. J Clin Endocrinol Metab1983; 56: 946–52.
18.
LewisVJSinghRNPTutivilerGFHuman growth hormone: A complex of proteins. Recent Prog Hormone Res1980; 36: 477–508.
19.
MittraI. Somatomedins and proteolytic bioactivation of prolactin and growth hormone. Cell1984; 38: 347–8.
20.
GuilleminRBrazeauPBöhlenPGrowth hormone-releasing factor from a human pancreatic tumour that caused acromegaly. Science1982; 218: 585–7.
21.
RosenthalSMSchriockEAKaplanSLSynthetic human pancreas growth hormone-releasing factor (hp GRF1–44-NH2) stimulates growth hormone secretion in normal men. J Clin Endocrinol Metab1983; 57: 677–9.
22.
HindmarshPCMathewsDRBrainCEThe half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatin. Clin Endocrinology1989; 30: 443–50.
23.
UnderwoodLEAzumiKVoinaSJVan WykJJ. Growth hormone levels during sleep in normal and growth hormone deficient children. Paediatrics1971; 48: 946–54.
24.
Van WykJJ. The somatomedins: Biological actions and physiologic control mechanisms. In: LiCH ed. Hormonal Proteins and Peptides, Vol 12. New York: Academic Press1984; 81–125.
25.
SchalchDSHeinrichVEDrazninBRole of the liver in regulating somatomedin activity: Hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology1979; 104: 1143–51.
26.
BaumannGAmburnKShawMS. The circulating growth hormone binding-protein complex: A major constituent of plasma GH in man. J Clin Endocrinol Metab1988; 122: 976–84.
27.
LeungDWSpencerSACachianesGGrowth hormone receptor and serum binding protein: Purification, cloning and expression. Nature1987; 330: 537–43.
28.
DaughadayWHTrivediBLauteroT. Serum125I hGH binding protein in non-GH deficient canine and porcine dwarfs (abstract)Prog Endoc Soc Annual Meeting1987; 97.
29.
SilbergeldALazarLErsterBKeretRSerum growth hormone binding protein activity in healthy neonates, children and young adults: Correlation with age, height and weight. Clin Endocrinology1989; 31: 295–303.
30.
LaronZ. Syndrome of familial dwarfism and high plasma immunoreactive growth hormone. Isr J Med Sci1974; 10: 1247–53.
31.
EshetRLaronZPertzelanADintzmanM. Defect of human growth hormone receptors in the liver of two patients with Laron type dwarfism. Isr J Med Sci1984; 20: 8–11.
32.
SalmonWDDaughadayWH. A hormonally controlled serum factor which stimulates sulphate incorporation by cartilage in vitro. J Lab Clin Med1957; 49: 825–36.
33.
DaughadayWHHallKRabenMSSomatomedin: A proposed designation for the sulphation factor. Nature1972; 235: 107.
34.
DaughadayWHHallKSalmonWDOn the nomenclature of the somatomedins and insulin-like growth factors. J Clin Endocrinol Metab1987; 65: 1075–6.
35.
RinderknechtEHumbelRE. Polypeptides with non suppressible insulin-like and cell promotion activities in human serum. Isolation, chemical characterisation and some biological properties of forms I and II. Proc Natl Acad Sci1976; 73: 2365–9.
36.
RinderknechtEHumbelRE. The aminoacid sequence of human insulin-like growth factor-I and its structural homology with proinsulin. J Biol Chem1978; 253: 2769–76.
D'ErcoleAJStilesADUnderwoodLE. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci1984; 81: 935–9.
39.
HollyJMPWassJAH. Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J Endocrinol1989; 112: 611–18.
40.
SkottnerAClarkRGRobinsonICFryklundL. Recombinant human insulin-like growth factor: Testing the hypothesis in hypophysectomized rats. J Endocrinol1987; 112: 123–32.
41.
TealeJDMarksV. Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia. Clin Endocr1990; 33: 87–98.
42.
BrissendenHEUllrichAFranckeU. Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor. Nature1984; 310: 781–4.
43.
Van den BrandeJLDu CajuMVL. An improved technique for measuring somatomedin activity in vitro. Acta Endocr (Khb)1974; 75: 233–42.
44.
HallK. Quantitative determination of the sulphation factor activity in human serum. Acta Endocr (Khb)1970; 63: 338–50.
45.
SchwalbeSLBettsPRRaynerPHWRuddBT. Somatomedin in growth disorders and chronic renal insufficiency in children. BMJ1977; 1 (i): 679–82.
46.
AshtonIKFrancisMJO. An assay for plasma somatomedin. 3H-thymidine incorporation by isolated rabbit chondrocytes. J Endocr1977; 74: 205–12.
47.
FurlanettoRWUnderwoodLEVan WykJJD'ErcoleAJ. Estimation of somatomedin C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest1977; 60: 648–57.
48.
ReiterEOLovingerRD. The use of a commercially available somatomedin C radioimmunoassay in patients with disorders of growth. J Pediatr1981; 99: 720–24.
49.
BalaRMBhaumickB. Radioimmunoassay of a basic somatomedin: Comparison of various assay techniques and somatomedin levels in various sera. J Clin Endocrinol Metab1979; 49: 770–7.
50.
FurlanettoRW. Pitfalls in the somatomedin C radioimmunoassay. J Clin Endocrinol Metab1982; 54: 1084–6.
51.
ClemmonsDRUnderwoodLEChatelainPGVan WykJJ. Liberation of immunoreactive somatomedin C from its binding proteins by proteolytic enzymes and heparin. J Clin Endocrinol Metab1983; 56: 384–9.
52.
ChatelainPGVan WykJJCopelandHCEffect of in vitro action of serum proteases or exposure to acid on measurable immunoereactive somatomedin C in serum. J Clin Endocrinol Metab1983; 56: 376–83.
53.
DaughadayWHMarizIKBlethenSL. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J Clin Endocrinol Metab1980; 51: 781–8.
54.
DaunceyMJShakespearRARuddBTIngramDL. Variations in somatomedin C/insulin-like growth factor-1 associated with environmental temperature and nutrition. Horm Metab Res1990; 22: 261–4.
55.
MesianoSYoungIRBrowneCAThorburneGD. Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors. J Endocr1988; 119: 453–60.
56.
SilbergeldAJaberLLilosPLaronZ. A comparison of IGF-I levels measured by two commercially available radioimmunoassays. Acta Endocr (Khb)1988; 119: 333–8.
57.
LindallAW. Serum Somatomedin C measurement with Immuno Nuclear Reagents. Minnesota: Immuno Nuclear Corp, 1951 Northwestern Avenue, Stillwater, Minnesota 55082, USA, 1985; 1–32.
58.
HintzRLLuiF. Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab1977; 45: 988–95.
59.
WhiteRMNissleySPMosesACThe growth hormone dependence of a somatomedin-binding protein in human serum. J Clin Endocrinol Metab1981; 53: 49–57.
60.
FurlanettoRW. The somatomedin C binding protein: Evidence for a heterologous subunit structure. J Clin Endocrinol Metab1980; 51: 12–19.
61.
HossenloppPSeurinDSegovia-QuinsonBBinouxM. Identification of an insulin-like growth factor binding protein in human cerebrospinal fluid with selective affinity for IGF-II. FEBS Lett1986; 208: 439–44.
62.
ChochinovRHMarizIKHajekASDaughadayWH. Characterisation of a protein in mid-term human amniotic fluid which reacts in the somatomedin C radioreceptor assay. J Clin Endocrinol Metab1977; 44: 902–8.
63.
RosenfeldRGPhamHOhYIdentification of insulin-like growth factor binding protein-2 (IGF-BP-2) and a low molecular weight IGF-BP in human seminal plasma. J Clin Endocrinol Metab1990; 70: 551–3.
64.
BallardJBaxterRCBinouxMOn the nomenclature of the IGF binding proteins. Acta Endocr (Khb)1989; 121: 751–2.
65.
BaxterRC. Characterisation of the acid-labile subunit of the growth hormone dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab1988; 67: 265–72.
66.
HardouinSHossenloppPSegovia-QuinsonBHeterogeneity of insulin-like growth factor binding proteins and relationship between structure and affinity I. Circulating forms in man. Eur J Biochem1987; 170: 121–32.
67.
HintzRLLiuFRosenfeldRGKempSF. Plasma somatomedin-binding proteins in hypopituitarism: Changes during hormone therapy. J Clin Endocrinol Metab1981; 53: 100–4.
68.
RosenfeldRGPhamHConoverCAStructural and immunological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids. J Clin Endocrinol Metab1989; 68: 638–46.
69.
HollyJMPBiddlecombeRADungerDBCircadian variation of GH independent IGF-binding protein in diabetes mellitus and its relationship to insulin: A new role for insulin?Clin Endocrinol1988; 29: 667–75.
70.
HollyJMPSmithCPDungerDBLevels of the small insulin-like growth factor binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty. J Endocrinol1989; 121: 383–7.
71.
BinouxMHossenloppPHardouinSSomatomedin (insulin-like growth factor) binding proteins: Molecular forms and regulation. Horm Res1986; 24: 141–51.
72.
BaxterRCMartinJL. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest1986; 78: 1504–12.
HossenloppPSeurinDSegovia-QuinsonBAnalysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem1986; 154: 138–43.
75.
HardouinSGourmelenMNoguiezPMolecular forms of serum insulin-like growth factor (IGF) binding proteins in man: Relationship with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab1989; 69: 1291–301.
76.
GelatoMCGaynesLAGreensteinLANissleySP. Heterogeneity of binding subunits of the human 150K insulin-like growth factor binding protein. J Clin Endocrinol Metab1990; 70: 879–87.
77.
BaxterRCMartinJL. Binding proteins for the insulin-like growth factors: Structure, regulation and function. Prog Growth Factor Res1989; 1: 49–68.
78.
DaughadayWHWardAPGoldbergACCharacterisation of somatomedin binding in human serum by ultra centrifugation and gel filtration. J Clin Endocrinol Metab1982; 55, 916–21.
79.
GulerHPZapfJSchmidCFroeschER. Insulin-like growth factor I & II in healthy man: Estimation of half-lives and production rates. Acta Endocr (Khb)1989; 121: 753–8.
80.
SchalchDSHeinrichVEDrazninBRole of the liver in regulating somatomedin activity: Hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology1979; 104: 1143–51.
81.
WhiteRMNissleySPMosesACThe growth hormone dependence of a somatomedin-binding protein in human serum. J Clin Endocrinol Metab1981; 53: 49–57.
82.
JulkunenMKoistinenRAalto-SetäläKPrimary structure of human insulin-like growth factor binding protein/placental protein 12 and tissue specific expression of its mRNA. FEBS Lets1988; 236: 295–302.
83.
BinkertCLandwehrJMaryJLCloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGF BP-2). EMBO J1989; 8: 2497–502.
84.
WoodWICachianesGHenzelJCloning and expression of the growth hormone dependent insulin-like growth factor binding protein. Mol Endocrinol1988; 2: 1176–85.
85.
DaughadayWHMarizIKTrivediB. Preferential binding site for insulin-like growth factor II in human and rat placental membranes. J Clin Endocr Metab1981; 53: 282–8.
86.
HillDJCraceCRFowlerLCultured fetal rat myoblasts release peptide growth factors which are immunologically and biologically similar to somatomedin. J Cell Physiol1984; 119: 349–58.
87.
ClemmonsDRElginRGJamesPE. Somatomedin C binding to cultured human fibroblasts is dependent on donor age and culture density. J Clin Endocr Metab1986; 63: 996–1001.
88.
MorganDORothRA. Identification of a monoclonal antibody which can distinguish between two distinct species of the type I receptor for insulin-like growth factor. Biochem Biophys Res Com1986; 138: 1341–7.
89.
HillDJAndrewsSJMilnerRDG. Cartilage response to plasma somatomedin activity in rats related to growth before and after birth. J Endocrin1981; 90: 133–42.
90.
ReedMJJamesVHT. Regulations of steroid synthesis and metabolism by growth factors. Clin Endocrinol1989; 31: 511–25.
91.
EvansAJWoodPJ. Development of an assay for human growth hormone in urine using commercially available reagents. Ann Clin Biochem1989; 26: 353–7.
RuddBTStylesLShakespearRAWilliamsJW. The cost of growth: A novel approach to the selection of a cost effective test for growth hormone deficiency. Proc Nat Meeting ACB1989: 43 (Abs).
94.
DeanHJKellettJGBalaRMThe effect of growth hormone treatment on somatomedin levels in growth hormone deficient children. J Clin Endocrinol Metab1982; 55: 1167–73.
95.
RudmanDKutnerMHChaulaRK. The short child with subnormal plasma somatomedin C. Pediatr Res1985; 19: 975–80.
96.
PreeceMATaylorAMHolderATDaggettP. The clinical application of somatomedin bioassay. In: GiordanoJJVan WykJJMinutoF eds. Somatomedins and Growth. New York: Academic Press, 1979; 263–70.
97.
RaynerPHWRuddBTThomasPHWilliamsJW. Growth hormone deficiency and the measurement of somatomedin C/IGF-I: The influence of sexual maturation. Clin Endocrinol1988; 28: 361–71.
98.
LunaAMWilsonDMWibbelsmanRCSomatomedins in adolescence: A cross sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels. J Clin Endocrinol Metab1983; 57: 268–71.
99.
UnderwoodLESmithEPVan WykJJSomatomedin C/insulin-like growth factor-I regulation and clinical applications. In: RaitiSTolmanRA eds. Human Growth Hormone. New York: Plenum Medical1986; 609–19.
100.
CraftWHUnderwoodLE. Effect of androgens on plasma somatomedin C/insulin-like growth factor-I responses to growth hormone. Clin Endocrinol1984; 20: 549–54.
101.
RosenfieldRLFurlanettoR. Physiologic testosterone or estradiol induction of puberty increases plasma somatomedin C. J Pediatr1985; 107: 415–17.
102.
FinkelsteinJWRoffwargHBoyarRMAge related change in the twenty-four hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab1972; 35: 665–70.
103.
SmithCPArchibaldHRThomasJMBasal and stimulated insulin levels rise with advancing puberty. Clin Endocrinol1988; 28: 7–14.
104.
KogawaMTakanoKAsakawaKInsulin stimulation of somatomedin-A production in monolayer cultures of rat hepatocytes. Acta Endocr (Khb)1983; 103: 385–90.
IsleyWLUnderwoodLEGlemmonsDR. Dietary components that regulate somatomedin C concentrations in humans. J Clin Invest1983; 71: 175–82.
107.
IsleyWLUnderwoodLEClemmonsDR. Changes in plasma somatomedin C in response to ingestion of diets with variable protein & energy content. J Parenteral Enteral Nutr1984; 8: 364–9.
108.
ClemmonsDRSeekMMUnderwoodLE. Supplemental essential amino acids augment the somatomedin C/IGF-I response to refeeding after fasting. Metabolism1985; 34: 391–5.
109.
BaxterRC. The somatomedins: Insulin-like growth factors. In: SpiegelHE ed. Advances in Clinical Chemistry. New York: Academic Press1986; 25: 49–115.
110.
TealeJDMarksV. The measurement of insulin-like growth factor I: Clinical applications and significance. Ann Clin Biochem1986; 23: 429–33.
111.
CharltonCPJShakespearRReayPReversal of malnutrition in children with cirrhosis: Effects of serum somatomedin C. Proc Brit Ped Ass1989: 699 (Abs).
112.
HintzRLSuskindRAmatoyakulKPlasma somatomedin and growth hormone values in children with protein-calorie malnutrition. J Ped1978; 92: 153–6.
113.
BusbyWHSnyderDKClemmonsDR. Radioimmunoassay of a 26000-dalton plasma insulin-like growth factor-binding protein: Control by nutritional variables. J Clin Endocrinol Metab1988; 67: 1225–30.
114.
LiuFPowellDRHintzRL. Characterization of insulin-like growth factor binding proteins in human serum from patients with chronic renal failure. J Clin Endocrinol Metab1990; 70: 620–8.
115.
LecornuMDavidLFrancoisR. Low serum somatomedin activity in coeliac disease. A misleading aspect in growth failure from asymptomatic coeliac disease. Helv Pediatr Acta1978; 33: 509–16.
116.
RosenfeldRGHintzRLJohansonAJMethyl human growth hormone and oxandrolone in Turner syndrome: Preliminary results of a prospective trial. J Pediatr1986; 109: 936–43.
117.
LaronZPertzelanAKarpMAdministration of growth hormone to patients with familial dwarfism with high immunoreactive growth hormone: Measurement of sulphation factor, metabolic and linear growth responses. J Clin Endocrinol Metab1971; 33: 332–42.
118.
BakwinH. Child care in Uganda and the Belgian Congo. J Paediat1954; 45: 430–6.
119.
MerimeeTJBaumannGDaughadayW. Growth hormone-binding protein II: Studies in pygmies and normal statured subjects. J Clin Endocrinol Metab1990; 71: 1183–8.
120.
ZapfJWalterHFroeshER. Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumour hypoglycaemia. J Clin Invest1982; 68: 1321–30.
121.
RosenfeldRGWilsonDMLeePDKHintzRL. Insulin-like growth factors I and II in the evaluation of growth retardation. J Paediatr1986; 109: 428–33.
122.
SilbergeldALitwinABruchisSInsulin-like growth factor (IGF-I) in healthy children, adolescents and adults as determined by radioimmunoassay. Clin Endocrinol1986; 25: 67–74.
123.
DeanHJKellettJGBalaRMThe effect of growth hormone treatment on somatomedin levels in growth hormone deficient children. J Clin Endocrinol Metab1982; 55: 1167–73.
124.
PraderAIlligRSzékyJWagnerH. The effect of human growth hormone in hypopituitary dwarfism. Arch Dis Childh1964; 39: 535–44.
125.
HubbleD. Studies with human growth hormone. Arch Dis Childh1966; 41: 17–24.
126.
Powell-JacksonJWellerROKennedyPCreutzfeld-Jakob disease after administration of human growth hormone. Lancet1985; ii: 244–6.
127.
FrasierSDLippeBM. Clinical review II: The rational use of growth hormone during childhood. J Clin Endocrinol Metab1990; 71: 269–73.